Biochemical markers of placental dysfunction in assisted conception

References

• Allen, V.M., Wilson, R.D., Cheung, A., Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada & Reproductive Endocrinology Infertility Committee of the Society of Obstetricians and Gynaecologists of Canada. (2006). Pregnancy outcomes after assisted reproductive technology. Journal of Obstetrics and Gynecology Canada, 28, 220–250.
   PubMedGoogle Scholar
• Andersen, A.N., Goossens, V., Gianaroli, L., Felberbaum, R., de Mouzon, J., & Nygren, K.G. (2007). Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Human Reproduction, 22, 1513–1525.
   PubMed Web of Science ®Google Scholar
• Auger, J., & Jouannet, P. (2005). Age and male fertility: biological factors. Revue d'Epidemiologie et de Sante Publique, 53, 2S25–2S35.
   PubMed Web of Science ®Google Scholar
• Basso, O., & Baird, D.D. (2003). Infertility and preterm delivery, birth weight, and Caesarean section: a study within the Danish National Birth Cohort. Human Reproduction, 18, 2478–2484.
   PubMed Web of Science ®Google Scholar
• Bi, S., Gavrilova, O., Gong, D.W., Mason, M.M., & Reitman, M. (1997). Identification of a placental enhancer for the human leptin gene. Journal of Biological Chemistry, 272, 30583–30588.
   PubMed Web of Science ®Google Scholar
• Bloise, E., Lin, W., Liu, X., Simbulan, R., Kolahi, K.S., Petraglia, F., et al. (2012). Impaired placental nutrient transport in mice generated by in vitro fertilization. Endocrinology, 153, 3457–3467.
   PubMed Web of Science ®Google Scholar
• Brzechffa, P.R., Jakimiuk, A.J., Agarwal, S.K., Weitsman, S.R., Buyalos, R.P., & Magoffin, D.A. (1996). Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 81, 4166–4169.
   PubMed Web of Science ®Google Scholar
• Budak, E., Fernández Sánchez, M., Bellver, J., Cerveró, A., Simón, C., & Pellicer, A. (2006). Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system. Fertility & Sterility, 85, 1563–1581.
   PubMed Web of Science ®Google Scholar
• Burton, G.J., Hempstock, J., & Jauniaux, E. (2003). Oxygen, early embryonic metabolism and free radical-mediated embryopathies. Reproductive Biomedicine Online, 6, 84–96.
   PubMedGoogle Scholar
• Chappell, L.C., Seed, P.T., Briley, A., Kelly, F.J., Hunt, B.J., Charnock-Jones, D.S., et al. (2002a). A longitudinal study of biochemical variables in women at risk of preeclampsia. American Journal of Obstetrics and Gynecology, 187, 127–136.
   PubMed Web of Science ®Google Scholar
• Chappell, L.C., Seed, P.T., Kelly, F.J., Briley, A., Hunt, B.J., Charnock-Jones, D.S., et al. (2002b). Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. American Journal of Obstetrics and Gynecology, 187, 777–784.
   PubMed Web of Science ®Google Scholar
• Chehab, F.F., Mounzih, K., Lu, R., & Lim, M.E. (1997). Early onset of reproductive function in normal female mice treated with leptin. Science, 275, 88–90.
   PubMed Web of Science ®Google Scholar
• Clausen, T., Djurovic, S., Reseland, J.E., Berg, K., Drevon, C.A., & Henriksen, T. (2002). Altered plasma concentrations of leptin, transforming growth factor-beta (1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta, 23, 380–385.
   PubMed Web of Science ®Google Scholar
• Collier, A.C., Miyagi, S.J., Yamauchi, Y., & Ward, M.A. (2009). Assisted reproduction technologies impair placental steroid metabolism. Journal of Steroid Biochemistry and Molecular Biology, 116, 21–28.
   PubMed Web of Science ®Google Scholar
• Coolman, M., de Groot, C.J., Steegers, E.A., Geurts-Moespot, A., Thomas, C.M., Steegers-Theunissen, R.P., et al. (2006). Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 128, 22–28.
   PubMed Web of Science ®Google Scholar
• Chardonnens, D., Cameo, P., Aubert, M.L., Pralong, F.P., Islami, D., Campana, A., et al. (1999). Modulation of human cytotrophoblastic leptin secretion by interleukin-1alpha and 17beta-oestradiol and its effect on HCG secretion. Molecular Human Reproduction, 5, 1077–1082.
   PubMed Web of Science ®Google Scholar
• Diab, A.E., El-Behery, M.M., Ebrahiem, M.A., & Shehata, A.E. (2008). Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. International Journal of Gynaecology and Obstetrics, 102, 146–151.
   PubMed Web of Science ®Google Scholar
• Dickey, R.P., Taylor, S.N., Lu, P.Y., Sartor, B.M., Storment, J.M., Rye, P.H., et al. (2002). Spontaneous reduction of multiple pregnancy: incidence and effect on outcome. American Journal of Obstetrics and Gynecology, 186, 77–83.
   PubMed Web of Science ®Google Scholar
• Dotsch, J., Nusken. K.D., Knerr, I., Kirschbaum, M., Repp, R., & Rascher, W. (1999). Leptin and neuropeptide Y gene expression in human placenta: ontogeny and evidence for similarities to hypothalamic regulation. Journal of Clinical Endocrinology and Metabolism, 84, 2755–2758.
   PubMed Web of Science ®Google Scholar
• Draper, E.S., Kurinczuk, J.J., Abrams, K.R., & Clarke, M. (1999). Assessment of separate contributions to perinatal mortality of infertility history and treatment: a case-control analysis. Lancet, 353, 1746–1749.
   PubMed Web of Science ®Google Scholar
• Ghazi, H.A., Spielberger, C., & Kallen, B. (1991). Delivery outcome after infertility – a registry study. Fertility and Sterility, 55, 726–732.
   PubMed Web of Science ®Google Scholar
• Guibourdenche, J., Tarrade, A., Laurendeau, I., Rochette-Egly, C., Chambon, P., Vidaud, M., et al. (2000). Retinoids stimulate leptin synthesis and secretion in human syncytiotrophoblast. Journal of Clinical Endocrinology and Metabolism, 85, 2550–2555.
   PubMed Web of Science ®Google Scholar
• Hansen, M., Bower, C., Milne, E., de Klerk, N., & Kurinczuk, J.J. (2005). Assisted reproductive technologies and the risk of birth defects – a systematic review. Human Reproduction, 20, 328–338.
   PubMed Web of Science ®Google Scholar
• Hasegawa, K., Furuichi, Y., Shimotsu, A., Nakamura, M. Yoshinaga, M., Kamitomo, M., et al. (2003). Associations between systemic status, periodontal status, serum cytokines levels, and delivery outcome in pregnant women with a diagnosis of threatened premature labour. Journal of Periodontology, 74, 1764–1770.
   PubMed Web of Science ®Google Scholar
• Helmerhorst, F.M., Perquin, D.A., Donker, D., & Keirse, M.J. (2004). Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies British Medical Journal, 328, 261.
   PubMed Web of Science ®Google Scholar
• Holness, M.J., Munns, M.J., & Sugden, M.C. (1999). Current concepts concerning the role of leptin in reproductive function. Molecular and Cellular Endocrinology, 157, 11–20.
   PubMed Web of Science ®Google Scholar
• Jackson, R.A., Gibson, K.A., Wu, Y.W., & Croughan, M.S. (2004). Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstetrics & Gynecology, 103, 551–563.
   PubMed Web of Science ®Google Scholar
• Jauniaux, E., Poston, L., & Burton, G.J. (2006). Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Human Reproduction Update, 12, 747–755.
   PubMed Web of Science ®Google Scholar
• Jawerbaum, A., & Gonzales, E. (2005). The role of alterations in arachidonic acid metabolism and nitric oxide homeostasis in rat models of diabetes during early pregnancy. Current Pharmaceutical Design, 11, 1327–1342.
   PubMed Web of Science ®Google Scholar
• Joy, J., Gannon, C., McClure, N., & Cooke, I. (2012). Is assisted reproduction associated with abnormal placentation? Pediatric and Developmental Pathology, 15, 306–314.
   PubMed Web of Science ®Google Scholar
• King, A., Balendran, N., Wooding, P., Carter, N.P., & Loke, Y.W. (1991). CD3 leucocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population. Developmental Immunology, 1, 169–190.
   PubMedGoogle Scholar
• Konstantina, A., Lazaris, A.C., Loannidis, E., Liossi, A., & Aroni, K. (2011). Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi. Melanoma Research, 21, 389–394.
   PubMed Web of Science ®Google Scholar
• Krauss, T., Pauer, H.U., & Augustin, H.G. (2004). Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertension in Pregnancy, 23, 101–111.
   PubMed Web of Science ®Google Scholar
• Kuhnert, B., & Nieschlag, E. (2004). Reproductive functions of the ageing male. Human Reproduction Update, 10, 327–339.
   PubMed Web of Science ®Google Scholar
• La Sala, G.B., Nucera, G., Gallinelli, A., Nicoli, A., Villani, M.T., & Blickstein, I. (2004). Spontaneous embryonic loss following in vitro fertilization: incidence and effect on outcomes. American Journal of Obstetrics and Gynecology, 191, 741–746.
   PubMed Web of Science ®Google Scholar
• Lam, C., Lim, K.H., & Karumanchi, S.A. (2005). Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension, 46, 1077–1085.
   PubMed Web of Science ®Google Scholar
• Lappas, M., Yee, K., Permezel, M., & Rice, G.E. (2005). Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. Journal of Endocrinology, 186, 457–465.
   PubMed Web of Science ®Google Scholar
• Laughlin, G.A., Morales, A.J., & Yen, S.S. (1997). Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism, 82, 1692–1696.
   PubMed Web of Science ®Google Scholar
• Lepercq, J., Guerre-Millo, M., Andre, J., Cauzac, M., & Hauguel-de Mouzon, S. (2003). Leptin: a potential marker of placental insufficiency. Gynecologic and Obstetric Investigation, 55, 151–155.
   PubMed Web of Science ®Google Scholar
• Mainigi, M.A., Olalere, D., Burd, I., Sapienza, C., Bartolomei, M., & Coutifaris, C. (2014). Peri implantation milieu: elucidating mechanisms of abnormal placentation and fetal growth. Biology of Reproduction, 90, 26.
   PubMed Web of Science ®Google Scholar
• Mantzoros, C.S., Cramer, D.W., Liberman, R.F., & Barbieri, R.L. (2000). Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles in normal women and in women with the polycystic ovarian syndrome. Human Reproduction, 15, 539–544.
   PubMed Web of Science ®Google Scholar
• McDonald, S.D., Murphy, K., Beyene, J., & Ohlsson, A. (2005). Perinatal outcomes of singleton pregnancies achieved by in vitro fertilization: a systematic review and meta-analysis. Journal of Obstetrics and Gynaecology Canada, 27, 449–459.
   PubMedGoogle Scholar
• McGovern, P.G., Llorens, A.J., Skurnick, J.H., Weiss, G., & Goldsmith, L.T. (2004). Increased risk of preterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis. Fertility and Sterility, 82, 1514–1520.
   PubMed Web of Science ®Google Scholar
• Mise, H., Sagawa, N., Matsumoto, T., Yura, S., Nanno, H., Itoh, H., et al. (1998). Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. Journal of Clinical Endocrinology and Metabolism, 83, 3225–3229.
   PubMed Web of Science ®Google Scholar
• Muy-Rivera, M., Ning, Y., Frederic, I.O., Vadachkoria, S., Luthy, D.A., & Williams, M.A. (2005). Leptin, soluble leptin receptor and leptin gene polymorphism in relation to preeclampsia risk. Physiological Research/Academia Scientiarum Bohemoslovaca, 54, 167–174.
   PubMed Web of Science ®Google Scholar
• Nakamura, Y., Asakura, Y., Piras, B.A., Hirai, H., Tastad, C.T., Verma, M., et al. (2012). Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardium. PloS One, 7, e41736.
   PubMed Web of Science ®Google Scholar
• Newbern, D., & Freemark, M. (2011). Placental hormones and the control of maternal metabolism and fetal growth. Current Opinion in Endocrinology, Diabetes, and Obesity, 18, 409–416.
   PubMed Web of Science ®Google Scholar
• Olivennes, F., Rufat, P., Andre, B., Pourade, A., Quiros, M.C., & Frydman, R. (1993). The increased risk of complication observed in singleton pregnancies resulting from in-vitro fertilization (IVF) does not seem to be related to the IVF method itself. Human Reproduction, 8, 1297–1300.
   PubMed Web of Science ®Google Scholar
• Ozkan, S., Erel, C.T., Madazli, R., & Aydinli, K. (2005). Serum leptin levels in hypertensive disorder of pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 120, 158–163.
   PubMed Web of Science ®Google Scholar
• Palep-Singh, M., Picton, H.M., Vrotsou, K., Maruthini, D., & Balen, A.H. (2007). South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 134, 202–207.
   PubMed Web of Science ®Google Scholar
• Pandey, S., Shetty, A., Hamilton, M., Bhattacharya, S., & Maheshwari, A. (2012). Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systemic review and meta-analysis. Human Reproduction Update, 18, 485–503.
   PubMed Web of Science ®Google Scholar
• Polsani, S., Phipps, E., & Jim, B. (2013). Emerging new biomarkers of preeclampsia. Advances in Chronic Kidney Disease, 20, 271–279.
   PubMed Web of Science ®Google Scholar
• Purcell, K., Schembri, M., Frazier, L.M., Rall, M.J., Shen, S., Croughan, M., et al. (2007). Asian ethnicity is associated with reduced pregnancy outcomes after assisted reproductive technology. Fertility and Sterility, 87, 297–302.
   PubMed Web of Science ®Google Scholar
• Raunig, J.M., Yamauchi, Y., Ward, M.A., & Collier, A.C. (2011). Placental inflammation and oxidative stress in the mouse model of assisted reproduction. Placenta, 32, 852–858.
   PubMed Web of Science ®Google Scholar
• Redman, C.W., Sargent, I.L., & Staff, A.C. (2014). IFPA Senior Award Lecture: making sense of pre-eclampsia – two placental causes of preeclampsia? Placenta, 35, S20–S25.
   PubMed Web of Science ®Google Scholar
• Reith, A., Booth, N.A., Moore, N.R., Cruickshank, D.J., & Bennett, B. (1993). Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. British Journal of Obstetrics and Gynaecology, 100, 370–374.
   PubMedGoogle Scholar
• Romero, R., Chaiworapongsa, T., Erez, O., Tarca, A.L., Gervasi, M.T., Kusanovic, J.P., et al. (2010). An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study. Journal of Maternal-Fetal and Neonatal Medicine, 23, 1384–1399.
   PubMed Web of Science ®Google Scholar
• Romero, R., Nien, J.K., Espinoza, J., Todem, D., Fu, W., Chung, H., et al. (2008). A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. The Journal of Maternal-Fetal & Neonatal Medicine, 21, 9–23.
   PubMed Web of Science ®Google Scholar
• Sagawa, N., Yura, S., Itoh, H., Mise, H., Kakui, K., Korita, D., et al. (2002). Role of leptin in pregnancy – a review. Placenta, 23, S80–S86.
   PubMed Web of Science ®Google Scholar
• Salvatores, M., Gennarelli, G., Menato, G., & Massobrio, M. (2006). Leptin as a possible marker of augmented metabolic risk during pregnancy. Minerva Ginecologica, 58, 1–10.
   PubMedGoogle Scholar
• Semczuk-Sikora, A., Krzyzanowski, A., Kwiatek, M., & Semczuk, M. (2007). Maternal serum concentration of placental growth factor and endothelial growth factor in pregnancies complicated by preeclampsia. Ginekologia Polska, 78, 873–876.
   PubMedGoogle Scholar
• Sheppard, S.J., & Khalil, R. A. (2010). Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy. Cardiovascular & Hematological Disorders Drug Targets, 10, 33–52.
   PubMedGoogle Scholar
• Signore, C., Mills, J.L., Qian, C., Yu, K., Lam, C., Epstein, F.H., et al. (2006). Circulating angiogenic factors and placental abruption. Obstetrics and Gynecology, 108, 338–344.
   PubMed Web of Science ®Google Scholar
• Signore, C., Mills, J.L., Qian, C., Yu, K.F., Rana, S., Karumanchi, S.A., et al. (2008). Circulating soluble endoglin and placental abruption. Prenatal Diagnosis, 28, 852–858.
   PubMed Web of Science ®Google Scholar
• Silver, R.K., Wilson, R.D., Philip, J., Thom, E.A., Zachary, J.M., Mohide, P., et al.; NICHD EATA Trial Group. (2005). Late first-trimester placental disruption and subsequent gestational hypertension/preeclampsia. Obstetrics and Gynecology, 105, 587–592.
   PubMed Web of Science ®Google Scholar
• Soh, E.B., Mitchell, M.D., & Keelan, J.A. (2000). Does leptin exhibit cytokine-like properties in tissues of pregnancy? American Journal of Reproductive Immunology, 43, 292–298.
   PubMed Web of Science ®Google Scholar
• Solomon, C.G., & Seely, E.W. (2001). Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension, 37, 232–239.
   PubMed Web of Science ®Google Scholar
• Stark, J.M. (1993). Pre-eclampsia and cytokine induced oxidative stress. British Journal of Obstetrics and Gynaecology, 100, 105–109.
   PubMedGoogle Scholar
• Talaulikar, V.S., & Arulkumaran, S. (2012). Reproductive outcomes after assisted conception. Obstetrical & Gynecological Survey, 67, 566–583.
   PubMed Web of Science ®Google Scholar
• Teixeira, P.G., Cabral, A.C., Andrade, S.P., Reis, Z.S., da Cruz, L.P., Pereira, J.B., et al. (2008). Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Hypertension in Pregnancy, 27, 65–73.
   PubMed Web of Science ®Google Scholar
• Thomson, F., Shanbhag, S., Templeton, A., & Bhattacharya, S. (2005). Obstetric outcome in women with subfertility. BJOG, 112, 632–637.
   PubMed Web of Science ®Google Scholar
• Trundley, A. & Moffett, A. (2004). Human uterine leucocytes and pregnancy. Tissue Antigens, 63, 1–12.
   PubMed Web of Science ®Google Scholar
• Tsatsaris, V., Goffin, F., Munaut, C., Brichant, J.F., Pignon, M.R., & Noel, A. (2003). Over expression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiolological consequences. Journal of Clinical Endocrinology and Metabolism, 88, 5555–5563.
   PubMed Web of Science ®Google Scholar
• Yasmin, H., Hassan, I., Vanga, P., Subramanium, M., & Adeghe, J.H. (2006). Adverse obstetric outcome in women with a history of infertility: a retrospective study. Journal of Obstetrics and Gynaecology, 26, 35–36.
   Google Scholar
• Zhang, Y., Cui, Y., Zhou, Z., Sha, J., Li, Y., & Liu, J. (2010). Altered global gene expressions of human placentae subjected to assisted reproductive technology treatments. Placenta, 31, 251–258.
   PubMed Web of Science ®Google Scholar